Monday, Apr 12, 2021
Bermuda News Online
Add Your News
‘Up to 80%’ of people in Sicily refusing AstraZeneca’s Covid-19 vaccine over safety concerns
The vast majority of people offered the Oxford/AstraZeneca anti-Covid vaccine Vaxzevria on the southern Italian island of Sicily are refusing to take it, according to the region’s president, Nello Musumeci.
China Mulls Mixing Different COVID-19 Vaccines To Improve Efficacy Of Jabs
Authorities have to "consider ways to solve the issue that efficacy rates of existing vaccines are not high", Chinese media outlet The Paper reported.
Are Covid passports a threat to liberty? It depends on how you define freedom
The pandemic is once again causing governments to pit incompatible ideas of freedom against each other
MeToo-19: Brazil prostitutes strike for first-line Covid shots
Prostitutes in the city of Belo Horizonte in southeast Brazil have gone on strike for a week, demanding to be included in the group of front-line workers receiving priority coronavirus vaccines.
Airlines blast Britain's travel restart plan, Jet2 cancels holidays until June
British travel company Jet2 said it was cancelling holidays until late June, blaming uncertainty in UK government plans for restarting international travel, which were condemned by airlines.
UK recognition of EU’s vaccine effort would not go amiss, says Brussels
Europe could have fully vaccinated 70% of adults before UK reaches its target, says head of EU taskforce
Greta Thunberg says she will not attend Cop26 climate summit
Swedish activist says uneven Covid vaccine rollout means countries would not participate on even terms
HSBC and Asian Development Bank join forces in $300 million vaccine financing
HSBC and the Asian Development Bank (ADB) will provide a combined $300 million in financing to help Asia’s supply chains boost manufacturing capacity for COVID-19 vaccines, the two lenders said on Friday.
Mandatory vaccines are ‘necessary in democratic society,’ don’t infringe human rights, EU court rules
Making children get jabs for common diseases is ‘necessary in democratic society’ and is in their best interests, the European Court for Human Rights (ECHR) ruled on Thursday in a landmark decision against anti-vaxxers.
Covid segregation? Venezuelan mayor in hot water after placing warning signs on homes of people who tested positive for virus
A mayor in central Venezuela has become the target of a government inquiry, after he began posting red markings on homes with Covid-positive residents, apparently as a way to warn locals to stay away.
‘Biopolitical surveillance regimes’: Vaccine passports reveal the growing authoritarian tendencies of Western governments
Forcing citizens to carry digital certificates showing that they’ve had the jab - and barring them from events and buildings if they haven’t - is a dangerous step that will create a two-tier society.
UK Reassures On AstraZeneca After Advising Under-30s Take Other Vaccines
Officials said the suggestion that under-30s should be offered an alternative did not reflect any serious safety concerns, just a "vanishingly" rare possible side effect.
Australia Halts AstraZeneca Vaccine For Under 50s Over Blood Clot Concerns
In a further setback for Australia's already halting coronavirus vaccine rollout, officials said the AstraZeneca shot should no longer be given to people under the age of 50, unless they had already received a first dose without any ill ...
UK-Made AstraZeneca Vaccines Quietly Sent To Australia: Report
As countries race to vaccinate their populations against the coronavirus, the export of immunisations has come into dispute wherever large numbers of people are awaiting a shot.
Elon Musk Weighs In On Vaccines, Again, Gets Mixed Reactions
Elon Musk said on Twitter that the science behind vaccines was "unequivocal".
Jamie Dimon sounds the alarm on the future of American prosperity
Jamie Dimon is very bullish on the US economic recovery from the pandemic. And yet the JPMorgan Chase CEO is deeply concerned about the future of America.
AstraZeneca vaccine: How do you weigh up the risks and benefits?
For most people currently being offered the Oxford-AstraZeneca vaccine, the benefits clearly outweigh the risks.
Belgium Restricts AstraZeneca Covid Vaccine To Over 55s
The suspension of the jab for adults aged 18 to 55 is based on "recent scientific advice," the health ministry said in a statement, adding that people in that age bracket would be offered jabs from BioNTech/Pfizer or Moderna instead.
UK Covid Variant Now Most Common Strain In US
The strain, known as B.1.1.7, was identified in Britain last fall and has since been detected in 52 jurisdictions in the United States, U.S. Centers for Disease Control and Prevention Director Dr. Rochelle Walensky told reporters at a Wh...
79 Blood Clots, 19 Deaths After Taking AstraZeneca Vaccine
"By the 31st of March over 20 million doses having been given, we have had 79 cases reported. Of the 79 cases, 19 people have sadly died," June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA) said.
UK To Offer AstraZeneca Alternative To Under-30s Over Blood Clot Concerns
"Adults who are aged 18 to 29 years old who do not have an underlying health condition... should be offered an alternative Covid-19 vaccine in preference to the AstraZeneca vaccine," Wei Shen Lim of the Joint Committee on Vaccination and...
UK Starts Moderna Jabs As AstraZeneca Probed
The Moderna vaccine, which is already being delivered in Europe and the United States, joined ones from AstraZeneca-Oxford University and Pfizer-BioNTech in Britain's armoury against Covid-19.
Oxford halts trials with AstraZeneca vaccine in minors
The University of Oxford has stopped testing its COVID-19 vaccine - developed with AstraZeneca - in children and adolescents until the UK drug regulatory agency (MHRA) provides more information on its possible side effects.
University of Oxford pauses pediatric trial of its vaccine with AstraZeneca, pending review by UK regulator
A pediatric trial of the Oxford-AstraZeneca vaccine has been paused pending a review by the UK's medicines regulator of rare blood clot cases in adults, a University of Oxford spokesperson told CNN Tuesday.
Add Your News